Compare ALKS & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | ALHC |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.4B |
| IPO Year | 2012 | 2021 |
| Metric | ALKS | ALHC |
|---|---|---|
| Price | $38.99 | $18.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $43.43 | $23.13 |
| AVG Volume (30 Days) | 1.7M | ★ 4.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | N/A | ★ 0.05 |
| Revenue | $1,475,899,000.00 | ★ $3,948,719,000.00 |
| Revenue This Year | $24.26 | $33.69 |
| Revenue Next Year | $4.47 | $24.74 |
| P/E Ratio | ★ N/A | $368.40 |
| Revenue Growth | N/A | ★ 46.06 |
| 52 Week Low | $25.17 | $11.63 |
| 52 Week High | $38.45 | $23.87 |
| Indicator | ALKS | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 71.82 | 42.36 |
| Support Level | $27.65 | $16.18 |
| Resistance Level | N/A | $20.71 |
| Average True Range (ATR) | 1.29 | 1.14 |
| MACD | 0.34 | -0.37 |
| Stochastic Oscillator | 87.89 | 33.88 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.